MYT1L and Alzheimer disease: MYT1L is a gene expressed exclusively in neurons that reprograms embryonic and infant fibroblasts into functional neurons and therefore acts as the critical regulator in the development of the nervous system, suggesting that MYT1L might be a potential treatment strategy for AD patients (Li et al., 2012).